Educational Program for Kidney Disease
(CKD-EDU Trial)

Recruiting in Palo Alto (17 mi)

Overseen byFahad Saeed, MD

Age: 65+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: University of Rochester

No Placebo Group

Trial Summary

What is the purpose of this trial?The investigators are conducting a study to see which program better helps older patients with kidney disease choose their treatment. Investigators are also investigating if either program can reduce the number of hospital or emergency room visits in the first 6 months of the study, as well as potentially improve end-of-life care for older adults. Half of the participants will receive Program A, while the other half will receive Program B. Investigators will compare the two groups to see which participants feel better prepared about their kidney therapy decisions, experience improved end-of-life care, and have fewer emergency room visits and hospital admissions. Participants in Program A will receive information from the National Kidney Foundation and meet with a kidney therapy educator. Participants in Program B will get information about kidney disease treatment and meet with a decision-support specialist who's an expert in decision-making.

Eligibility Criteria

This trial is for older adults with advanced chronic kidney disease. Participants should be interested in learning about their condition and treatment options to make better health decisions. Specific eligibility details are not provided, but typically, participants must meet certain health criteria.

Inclusion Criteria

Speaks English

I have not decided on starting dialysis.

I am 75 years old or older.

+1 more

Exclusion Criteria

I have chosen either dialysis or active medical care without it.

I have seen a Palliative Care specialist or am enrolled in hospice.

I am currently receiving dialysis.

+1 more

Participant Groups

The study tests if an educational program (CKD-EDU) plus meetings with a palliative care specialist can help patients make more informed kidney therapy choices compared to usual nephrology care alone. The impact on emergency visits, hospital admissions, and end-of-life care quality will also be assessed.

2Treatment groups

Active Control

Group I: Program AActive Control1 Intervention

Kidney therapy education and support with kidney therapy educator.

Group II: Program BActive Control1 Intervention

Behavioral: CKD-EDU Palliative care-based decision-support intervention for support with kidney therapy decision-making.